258 related articles for article (PubMed ID: 16681044)
1. Sterility of non-preservative eye drops.
Prabhasawat P; Chotikavanich S; Leelaporn A
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of preservative free eye drops in multiple application containers.
Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
[TBL] [Abstract][Full Text] [Related]
3. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
Kodym A; Zawisza T; Buźka K; Kukuła H
Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of eye drops.
Taşli H; Coşar G
Cent Eur J Public Health; 2001 Aug; 9(3):162-4. PubMed ID: 11505742
[TBL] [Abstract][Full Text] [Related]
5. Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
Montes JA; Johnson D; Jorgensen J; McElmeel ML; Fulcher LC; Kiel JW
Cornea; 2016 Jan; 35(1):122-6. PubMed ID: 26555587
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.
Kim MS; Choi CY; Kim JM; Chang HR; Woo HY
Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802
[TBL] [Abstract][Full Text] [Related]
7. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
[TBL] [Abstract][Full Text] [Related]
8. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
[TBL] [Abstract][Full Text] [Related]
9. [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects].
Sauer R; Blüthner K; Seitz B
Ophthalmologe; 2004 Jul; 101(7):705-9. PubMed ID: 14999414
[TBL] [Abstract][Full Text] [Related]
10. Stability and Sterility of Extemporaneously Prepared Nonpreserved Cefazolin, Ceftazidime, Vancomycin, Amphotericin B, and Methylprednisolone Eye Drops.
Ratprasatporn N; Wittayalertpanya S; Khemsri W; Chatsuwan T; Chongpison Y; Chamsai T; Wattanakijkarn M; Chansangpetch S
Cornea; 2019 Aug; 38(8):1017-1022. PubMed ID: 31090593
[TBL] [Abstract][Full Text] [Related]
11. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
Kodym A; Zawisza T; Napierała B; Kukuła H
Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Rosenthal RA; Buck SL; Henry CL; Schlech BA
J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
[TBL] [Abstract][Full Text] [Related]
14. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
[TBL] [Abstract][Full Text] [Related]
15. [Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at -20 degrees C].
Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
J Fr Ophtalmol; 2007 Oct; 30(8):807-13. PubMed ID: 17978677
[TBL] [Abstract][Full Text] [Related]
16. [Advances in preservative-free glaucoma drops].
Stefan C; Pop A; Cojocaru I
Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
[TBL] [Abstract][Full Text] [Related]
17. In vitro potency and stability of fortified ophthalmic antibiotics.
Arici MK; Sümer Z; Güler C; Elibol O; Saygi G; Cetinkaya S
Aust N Z J Ophthalmol; 1999 Dec; 27(6):426-30. PubMed ID: 10641902
[TBL] [Abstract][Full Text] [Related]
18. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
Kodym A; Marcinkowski A; Kukuła H
Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
[TBL] [Abstract][Full Text] [Related]
19. Stability of self-prepared fortified antibiotic eyedrops.
Lin CP; Tsai MC; Sun CY; Chen JY; Lin SR
Kaohsiung J Med Sci; 1999 Feb; 15(2):80-6. PubMed ID: 10089717
[TBL] [Abstract][Full Text] [Related]
20. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
